Kathleen C Davis, MD | |
2675 Central Ave, Billings, MT 59102-6686 | |
(406) 238-2500 | |
Not Available |
Full Name | Kathleen C Davis |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2675 Central Ave, Billings, Montana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407959489 | NPI | - | NPPES |
000092100 | Other | MT | BCBS PIN |
0011356 | Other | MT | MDCD PIN |
102016100 | Other | WY | MDCD PIN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | 5269 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kathleen C Davis, MD Po Box 35100, Billings, MT 59107-5100 Ph: (406) 238-2500 | Kathleen C Davis, MD 2675 Central Ave, Billings, MT 59102-6686 Ph: (406) 238-2500 |
News Archive
The same brain network that adults use when they hear angry vocalizations is at work in infants as young as six months old, an effect that is strongest in infants whose mothers spend the most time controlling their behavior, according to a new study in the open-access journal PLOS ONE by Chen Zhao of the University of Manchester, UK, and colleagues.
New research shows that protective immunity against HIV can be achieved without the presence of virus neutralizing antibodies in the blood. The study, published by Cell Press in the February issue of the journal Immunity, demonstrates that a vaccine which stimulates production of specific anti-HIV antibodies in the vaginal tissue was sufficient to protect monkeys from exposure to live virus.
The Cardiovascular Cell Therapy Research Network (CCTRN), a nationwide U.S. network funded by the National Institutes of Health's (NIH) National Heart, Lung and Blood Institute (NHLBI) has selected the Minneapolis Heart Institute- (MHI) as one of its seven U.S. centers of excellence.
A transformational leadership style—valued for stimulating innovation and worker performance—is also associated with increased well-being among employees, reports a study in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
Idera Pharmaceuticals, Inc. today announced that it will be presenting data from preclinical studies of its Toll-like receptor (TLR) inhibitor, IMO-8400, in models of systemic lupus erythematosus (SLE) and psoriasis, which suggest that IMO-8400 may be useful for the treatment of both indications.
› Verified 5 days ago
Dr. George Lanske, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Thomas E. Scarborough, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3860 Avenue B Ste C, Billings, MT 59102 Phone: 406-237-5500 Fax: 406-237-5510 | |
Michael R. Younker, DO Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 |